Tdspharm Revenue

Tdspharm had revenue of 5.58B KRW in the quarter ending June 30, 2025, a decrease of -30.84%. This brings the company's revenue in the last twelve months to 22.94B, down -23.44% year-over-year. In the year 2024, Tdspharm had annual revenue of 27.52B, down -8.42%.

Revenue (ttm)

22.94B

Revenue Growth

-23.44%

P/S Ratio

2.17

Revenue / Employee

n/a

Employees

n/a

Market Cap

49.83B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	27.52B	-2.53B	-8.42%
Dec 31, 2023	30.05B	4.46B	17.43%
Dec 31, 2022	25.59B	5.77B	29.11%
Dec 31, 2021	19.82B	1.80B	9.97%
Dec 31, 2020	18.02B	-1.19B	-6.19%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	5.03T
Celltrion	3.75T
Yuhan	2.17T
SK Biopharmaceuticals	620.28B
PharmaResearch	449.81B
Sam Chun Dang Pharm.	215.10B
ALTEOGEN	158.06B
LigaChem Biosciences	148.28B

Revenue Rankings